Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Movement of '336 at USPTO..Reexam Litigation Search ConductedWhich means?EOM

I take this as positive development as well.

Remember that during the shareholders meeting, Leckrone stated that all the prior art that prompted this new reexamination was reviewed in the prior reexamination which just recertified the patent. If that statement was correct, then this reexam was only issued because the paperwork for the recertification was not finalized. Now that everything is documented in the recertification, the '336 patent should be recertified a second time.

Share
New Message
Please login to post a reply